Reappraisal of the safety and effectiveness of Impella pumps
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://www.nature.com/articles/s41569-020-0333-8.pdf
Reference10 articles.
1. Rathi, V. K., Kesselheim, A. S. & Ross, J. S. The US Food and Drug Administration 515 program initiative: addressing the evidence gap for widely used, high-risk cardiovascular devices? JAMA Cardiol. 1, 117–118 (2016).
2. Abiomed. Investor Reports. Abiomed http://investors.abiomed.com (2019).
3. Amin, A. P. et al. The evolving landscape of Impella® use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation https://doi.org/10.1161/CIRCULATIONAHA.119.044007 (2019).
4. O’Neill, W. W. et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126, 1717–1727 (2012).
5. Ouweneel, D. M. et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump for treating cardiogenic shock: meta-analysis. J. Am. Coll. Cardiol. 69, 358–360 (2017).
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock;Journal of the American College of Cardiology;2022-05
2. Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock;American Heart Journal;2021-06
3. Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center;Catheterization and Cardiovascular Interventions;2020-12-16
4. Mechanical circulatory support devices in advanced heart failure: 2020 and beyond;Progress in Cardiovascular Diseases;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3